GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (BSP:A1SN34) » Definitions » Quick Ratio

Ascendis Pharma A/S (BSP:A1SN34) Quick Ratio : 0.54 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Ascendis Pharma A/S Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Ascendis Pharma A/S's quick ratio for the quarter that ended in Mar. 2024 was 0.54.

Ascendis Pharma A/S has a quick ratio of 0.54. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Ascendis Pharma A/S's Quick Ratio or its related term are showing as below:

BSP:A1SN34' s Quick Ratio Range Over the Past 10 Years
Min: 0.54   Med: 9.28   Max: 22.32
Current: 0.54

During the past 13 years, Ascendis Pharma A/S's highest Quick Ratio was 22.32. The lowest was 0.54. And the median was 9.28.

BSP:A1SN34's Quick Ratio is ranked worse than
88.55% of 1554 companies
in the Biotechnology industry
Industry Median: 3.515 vs BSP:A1SN34: 0.54

Ascendis Pharma A/S Quick Ratio Historical Data

The historical data trend for Ascendis Pharma A/S's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Quick Ratio Chart

Ascendis Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.74 14.02 7.28 4.63 2.50

Ascendis Pharma A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 2.65 2.56 2.50 0.54

Competitive Comparison of Ascendis Pharma A/S's Quick Ratio

For the Biotechnology subindustry, Ascendis Pharma A/S's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma A/S's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's Quick Ratio falls into.



Ascendis Pharma A/S Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Ascendis Pharma A/S's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(3754.844-1116.38)/1054.467
=2.50

Ascendis Pharma A/S's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(3594.728-1259.462)/4324.691
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Pharma A/S  (BSP:A1SN34) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Ascendis Pharma A/S Quick Ratio Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma A/S (BSP:A1SN34) Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma A/S (BSP:A1SN34) Headlines

No Headlines